Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 4Observational 2

Sponsor

Conditions

Arthritis, Rheumatoid 5Inflammatory Bowel Diseases 2Colitis, Ulcerative 2Spondylitis, Ankylosing 1Psoriasis 1Precancerous Conditions 1Melanoma 1Infections 1Hepatitis C 1Crohn Disease 1Arthritis 1

Interventions

Infliximab 2vedolizumab 1Standard of Care 1Proctocolectomy, Restorative 1Practice Guidelines as Topic 1Methods 1Laparoscopy 1Interviews as Topic 1Endoscopy 1Educational Status 1Early Intervention, Educational 1Dietary Fiber 1CT-P13 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Colitis, Ulcerative × Infliximab × Clear all
NCT03765450 2025-05-16

PROTOS

Alimentiv Inc.

Active not recruiting
18 enrolled

Colitis, Ulcerative

NCT03452501 2021-02-23

Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients

Hikma Pharmaceuticals LLC

Completed
157 enrolled

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡